Kayani Irfan, Conry Brendon G, Groves Ashley M, Win Thida, Dickson John, Caplin Martyn, Bomanji Jamshed B
Institute of Nuclear Medicine, University College Hospital, UCLH, London, United Kingdom.
J Nucl Med. 2009 Dec;50(12):1927-32. doi: 10.2967/jnumed.109.066639. Epub 2009 Nov 12.
Our purpose was to compare the performance of (68)Ga-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-d-Phe(1),Tyr(3)-octreotate (DOTATATE), a novel selective somatostatin receptor 2 PET ligand, and (18)F-FDG in the detection of pulmonary neuroendocrine tumors using PET/CT, with correlation of uptake and tumor grade on histology.
The imaging findings of the first 18 consecutive patients (8 men and 10 women) with pulmonary neuroendocrine tumors (11 typical carcinoids, 2 atypical carcinoids, 1 large cell neuroendocrine tumor, 1 small cell neuroendocrine carcinoma, 1 non-small cell lung cancer with neuroendocrine differentiation, and 2 cases of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia) who underwent (68)Ga-DOTATATE and (18)F-FDG PET/CT were reviewed. In all cases, the diagnosis was established on histology.
Of 18 patients, 15 had primary tumors (median size, 2.7 cm; range, 0.5-8 cm) and 3 had recurrent tumors. All typical carcinoids showed high uptake of (68)Ga-DOTATATE (maximum standardized uptake value [SUV(max)] >or= 8.2), but 4 of 11 showed negative or minimal (18)F-FDG uptake (SUV(max) = 1.7-2.9). All tumors of higher grade showed high uptake of (18)F-FDG (SUV(max) >or= 11.7), but 3 of 5 showed only minimal accumulation of (68)Ga-DOTATATE (SUV(max) = 2.2-2.8). Neither case of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia showed uptake of (68)Ga-DOTATATE or (18)F-FDG. Typical carcinoids showed significantly higher uptake of (68)Ga-DOTATATE and significantly less uptake of (18)F-FDG than did tumors of higher grade (P = 0.002 and 0.005). There was no instance of false-positive uptake of (68)Ga-DOTATATE, but there were 3 sites of (18)F-FDG uptake secondary to inflammation. (68)Ga-DOTATATE was superior to (18)F-FDG in discriminating endobronchial tumor from distal collapsed lung (P = 0.02).
Typical bronchial carcinoids showed higher and more selective uptake of (68)Ga-DOTATATE than of (18)F-FDG. Atypical carcinoids and higher grades had less (68)Ga-DOTATATE avidity but were (18)F-FDG-avid.
我们的目的是比较新型选择性生长抑素受体2正电子发射断层显像(PET)配体(68)镓-1,4,7,10-四氮杂环十二烷-N,N',N'',N'''-四乙酸-d-苯丙氨酸(1),酪氨酸(3)-奥曲肽(DOTATATE)和(18)氟-脱氧葡萄糖(FDG)在使用PET/CT检测肺神经内分泌肿瘤中的性能,并将摄取情况与组织学肿瘤分级相关联。
回顾了连续18例患有肺神经内分泌肿瘤(11例典型类癌、2例非典型类癌、1例大细胞神经内分泌肿瘤、1例小细胞神经内分泌癌、1例具有神经内分泌分化的非小细胞肺癌以及2例弥漫性特发性肺神经内分泌细胞增生)的患者(8名男性和10名女性)的成像结果,这些患者均接受了(68)Ga-DOTATATE和(18)F-FDG PET/CT检查。所有病例均经组织学确诊。
18例患者中,15例有原发性肿瘤(中位大小2.7 cm;范围0.5 - 8 cm),3例有复发性肿瘤。所有典型类癌均显示(68)Ga-DOTATATE高摄取(最大标准化摄取值[SUV(max)]≥8.2),但11例中有4例显示(18)F-FDG摄取阴性或最低(SUV(max)=1.7 - 2.9)。所有高级别肿瘤均显示(18)F-FDG高摄取(SUV(max)≥11.7),但5例中有3例仅显示(68)Ga-DOTATATE最低积聚(SUV(max)=2.2 - 2.8)。弥漫性特发性肺神经内分泌细胞增生的2例患者均未显示(68)Ga-DOTATATE或(18)F-FDG摄取。典型类癌显示(68)Ga-DOTATATE摄取显著高于高级别肿瘤,(18)F-FDG摄取显著低于高级别肿瘤(P = 0.002和0.005)。(68)Ga-DOTATATE未出现假阳性摄取情况,但有3个(18)F-FDG摄取部位继发于炎症。在区分支气管内肿瘤与远端肺萎陷方面,(68)Ga-DOTATATE优于(18)F-FDG(P = 0.02)。
典型支气管类癌显示(68)Ga-DOTATATE的摄取高于且更具选择性,高于(18)F-FDG。非典型类癌和高级别肿瘤的(68)Ga-DOTATATE亲和力较低,但对(18)F-FDG有亲和力。